NOT KNOWN DETAILS ABOUT HRD BARRIER

For the maintenance cure of Grownup patients with Innovative epithelial ovarian, fallopian tube, or Main peritoneal most cancers that are in finish or partial response to 1st-line platinum-centered chemotherapy and whose cancer is related to HRD-beneficial status defined by either: one) a deleterious or suspected deleterious BRCA mutation, and/or 2